OW 2025 4 - 7 November 2025

CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: the REDEFINE 1 Trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress oral presentation
GLP-1 RA
CagriSema
PHASE 3 (RCT)